HHS and CMS unveil Most Favored Nation drug pricing model targeting pharmaceutical manufacturers to align U.S. drug prices with international benchmarks and reduce costs.

Explore how Trump administration cuts to NIH funding, public health grants, and potential Medicaid changes disrupt U.S. health care research, public health efforts, and patient care access.

Explore how private equity's rise in U.S. health care consolidation affects hospitals, physician practices, care quality, costs, and regulatory responses.

Record health insurance enrollment on the 2025 exchanges driven by ACA subsidies faces uncertainty amid proposed federal cuts. CMS reports enrollment up 13%.

The Trump administration must decide whether to defend Biden-era mental health parity regulations requiring insurers to provide equitable mental health and addiction coverage. The decision impacts access, insurer compliance, and employer health plans.

The Bridge to Medicaid Act proposes temporary premium subsidies to close the Medicaid coverage gap for over 100,000 Alabamians in non-expansion states, enhancing access to affordable healthcare starting in 2026.

The Supreme Court hears Kennedy v. Braidwood Management, challenging the ACA's mandate for cost-free preventive services coverage affecting 150 million insured Americans. This case could reshape preventive care access under private health plans.

Ohio's Medicaid expansion proposal to keep children covered through age four faces political opposition over costs and eligibility concerns, impacting continuous coverage and pediatric care policy.

Overview of U.S. maternal health policy shifts including birthrate incentives, CDC funding cuts, and challenges in military insurance affecting pregnant women. Insights into insurance and regulatory impacts.

Exploring how proposed federal budget cuts of $880 billion over the next decade might affect the financial health and service availability at rural hospitals across the U.S.